Terms: = Brain cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Staging
454 results:
1. Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer.
Wegen S; Claus K; Linde P; Rosenbrock J; Trommer M; Zander T; Tuchscherer A; Bruns C; Schlößer HA; Schröder W; Eich ML; Fischer T; Schomäcker K; Drzezga A; Kobe C; Sabine Roth K; Weindler JJ
Radiat Oncol; 2024 Apr; 19(1):44. PubMed ID: 38575990
[TBL] [Abstract] [Full Text] [Related]
2. Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
Obrecht-Sturm D; Pfaff E; Mynarek M; Bison B; Rodehüser M; Becker M; Kietz S; Pfister SM; Jones DT; Sturm D; von Deimling A; Sahm F; Kortmann RD; Schwarz R; Pietsch T; Fleischhack G; Rutkowski S
J Neurooncol; 2024 Jan; 166(2):359-368. PubMed ID: 38253790
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D
Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076
[TBL] [Abstract] [Full Text] [Related]
4. Competing Risk Model to Determine the Prognostic Factors for Patients with Gliosarcoma.
Chen M; Huang L; Wang F; Xu X; Xu X
World Neurosurg; 2024 Mar; 183():e483-e494. PubMed ID: 38157982
[TBL] [Abstract] [Full Text] [Related]
5. PATIENT-RELATED FACTORS AND CLINICAL MANAGEMENT OUTCOMES OF RETINOBLASTOMA IN CALABAR, NIGERIA.
Nkanga ED; Nlemadim AC; Arazi M; Nkanga DG; Duke RE; Fabian ID; Nkanga ED; Odey FA; Meremikwu MM
West Afr J Med; 2023 Dec; 40(12 Suppl 1):S36-S37. PubMed ID: 38070170
[TBL] [Abstract] [Full Text] [Related]
6. FDG PET/CT Demonstrated Unilateral Striatum Hypometabolism in a Case of Advanced Nasopharyngeal cancer.
Lu XP; Chen AC; Wu MC; Tseng HC; Kao PF
Clin Nucl Med; 2024 Jan; 49(1):104-105. PubMed ID: 37976532
[TBL] [Abstract] [Full Text] [Related]
7. Intracranial Germ Cell Tumors.
Yeoh TDYY; Nga V; Kimpo M; Lo SS; Vellayappan B
Semin Neurol; 2023 Dec; 43(6):897-908. PubMed ID: 37963583
[TBL] [Abstract] [Full Text] [Related]
8. Pineal/germ cell tumors and pineal parenchymal tumors.
Ogiwara H; Liao YM; Wong TT
Childs Nerv Syst; 2023 Oct; 39(10):2649-2665. PubMed ID: 37831207
[TBL] [Abstract] [Full Text] [Related]
9. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic value of 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in acral melanoma-predominant Asian patients.
Chen KC; Chu PY; Li CY; Wang TH; Chiu YJ
J Chin Med Assoc; 2023 Nov; 86(11):975-980. PubMed ID: 37738518
[TBL] [Abstract] [Full Text] [Related]
11. [
Yang L; Xu S; Cheng L; Gao C; Cao S; Chang Z; Wang K
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4051-4063. PubMed ID: 37542659
[TBL] [Abstract] [Full Text] [Related]
12. Determination of PDK1, SLC2A1, EGFR, PTEN, CD276 Gene Expression Levels and IDH1 Gene R132H Polymorphism in brain Tumor Tissues.
Korkmaz S; Soylemez E; Soylemez Z; Solak M
Turk Neurosurg; 2023; 33(6):1086-1092. PubMed ID: 37528722
[TBL] [Abstract] [Full Text] [Related]
13. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract] [Full Text] [Related]
14. [WHO Histological Classification of Pituitary Tumors].
Nishioka H
No Shinkei Geka; 2023 Jul; 51(4):642-653. PubMed ID: 37491061
[TBL] [Abstract] [Full Text] [Related]
15.
Kersting D; Sandach P; Sraieb M; Wiesweg M; Metzenmacher M; Darwiche K; Oezkan F; Bölükbas S; Stuschke M; Umutlu L; Nader M; Hamacher R; Fendler WP; Wienker J; Eberhardt WEE; Schuler M; Herrmann K; Hautzel H
J Nucl Med; 2023 Oct; 64(10):1540-1549. PubMed ID: 37474272
[TBL] [Abstract] [Full Text] [Related]
16. Establishment of a prognostic risk prediction modelfor non-small cell lung cancer patients with brainmetastases: a retrospective study.
Hou F; Hou Y; Sun XD; Lv J; Jiang HM; Zhang M; Liu C; Deng ZY
PeerJ; 2023; 11():e15678. PubMed ID: 37456882
[TBL] [Abstract] [Full Text] [Related]
17. Treatment outcome of patients with synchronous oligometastatic non-small cell lung cancer in the immunotherapy era: Analysis of a real-life intention-to-treat population.
Jongbloed M; Bartolomeo V; Steens M; Dursun S; van de Lisdonk T; De Ruysscher DKM; Hendriks LEL
Eur J Cancer; 2023 Sep; 190():112947. PubMed ID: 37451182
[TBL] [Abstract] [Full Text] [Related]
18. Identification of
Galvez T; Berkane I; Thézenas S; Eberlé MC; Flori N; Guillemard S; Ilonca AD; Santoro L; Kotzki PO; Senesse P; Deshayes E
Nutrients; 2023 Jul; 15(13):. PubMed ID: 37447367
[No Abstract] [Full Text] [Related]
19. Applications of artificial intelligence in magnetic resonance imaging of primary pediatric cancers: a scoping review and CLAIM score assessment.
Tsang B; Gupta A; Takahashi MS; Baffi H; Ola T; Doria AS
Jpn J Radiol; 2023 Oct; 41(10):1127-1147. PubMed ID: 37395982
[TBL] [Abstract] [Full Text] [Related]
20. Head-to-Head Comparison of [
Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
[No Abstract] [Full Text] [Related]
[Next]
